C30.1 — Malignant neoplasm of middle ear
C30.1 is a billable, specific ICD-10-CM code for malignant neoplasm of middle ear. It is valid for submission on a claim.
Excludes1 — never code together
These conditions cannot occur together. Billing both on the same encounter is a denial.
Inclusion terms
Alternative wordings a physician may use in the chart for this same code.
- Malignant neoplasm of antrum tympanicum
- Malignant neoplasm of auditory tube
- Malignant neoplasm of eustachian tube
- Malignant neoplasm of inner ear
- Malignant neoplasm of mastoid air cells
- Malignant neoplasm of tympanic cavity
Risk adjustment
C30.1 risk-adjusts. Under the CMS-HCC V28 model it maps to this category:
- HCC 21 Lymphoma and Other Cancers0.671 RAF
Coefficient shown for the Community Non-dual Aged segment. A higher HCC in the same hierarchy will suppress this one, so capturing it does not always add score.
Medicare coverage
C30.1 is named in 58 Medicare coverage policies — 58 listing it as supporting medical necessity. Which of them applies to you depends on your Medicare contractor, and coverage genuinely differs by state.
- A52450Billing and Coding: Paclitaxel (e.g., Taxol®/Abraxane ™)
- A52479Oral Anticancer Drugs - Policy Article
- A52479Oral Anticancer Drugs - Policy Article
- A52479Oral Anticancer Drugs - Policy Article
Related codes at this level
Codes that share C30. If C30.1 is not quite right, the correct code is usually one of these.
Questions about C30.1
- Is C30.1 a billable ICD-10-CM code?
- Yes. C30.1 is a billable, specific ICD-10-CM code and is valid for submission on a claim.
- Where does C30.1 sit in the tabular list?
- Neoplasms (C00-D49), in the block Malignant neoplasms of respiratory and intrathoracic organs (C30-C39).
- What cannot be coded together with C30.1?
- C30.1 carries an Excludes1 note, which means the conditions it lists can never be coded together with it on the same encounter.